Rapid prenatal diagnosis and exclusion of epidermolysis bullosa using novel antibody probes.
Prenatal diagnosis of recessive dystrophic epidermolysis bullosa was successfully achieved at 19 weeks' gestation by indirect immunofluorescence examination of a fetal skin biopsy sample using the monoclonal antibody LH 7:2. The abortus displayed marked blistering and the diagnosis was confirmed by transmission electron microscopy (TEM). In 3 further pregnancies at risk for lethal junctional epidermolysis bullosa the diagnosis was excluded using the polyclonal antibody AA3. In all these studies the results were available within 4 h of receiving the samples. These new techniques offer a quick and simple alternative to TEM for midtrimester prenatal diagnosis of 2 severe recessive forms of epidermolysis bullosa.
D000032:Abortion, Therapeutic; D000328:Adult; D000906:Antibodies; D000911:Antibodies, Monoclonal; D003937:Diagnosis, Differential; D004817:Epidermis / Q000648:ultrastructure; D004820:Epidermolysis Bullosa / Q000473:pathology*; D005321:Extraembryonic Membranes / Q000648:ultrastructure; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D011247:Pregnancy; D011296:Prenatal Diagnosis
D000906:Antibodies; D000911:Antibodies, Monoclonal